Infection and drug resistance
Indexed In
ulakbim MEP: - Ödeme: 3750 Yılı: 2019
Short Name Infect Drug Resist
Abbreviated Name IDR
ISSN 1178-6973
Aim and Scope Aims and Scope Editor-in-Chief: Professor Suresh Antony Infection and Drug Resistance is an international, peer-reviewed, open access journal that focuses on the optimal treatment of infection (bacterial, fungal and viral) and the development and institution of preventative strategies to minimize the development and spread of resistance. The journal is characterized by the rapid reporting of high-quality original research, reviews, guidelines, expert opinions, commentary and clinical studies in all areas of infection and drug resistance. Specific topics covered by the journal include: Development of novel anti-infectives Optimal use of existing anti-infectives Pathogenesis and etiology of infectious disease Proteomic and genomic studies in resistant organisms Mechanisms of resistance development Infection control in hospitals and the community Diagnosis and early detection of infection Clinical management of infection Clinical management of antibiotic resistance (e.g. in transplant and HIV patients) Epidemiology of infection and antibiotic resistance Education and prevention of drug resistance Patient adherence and satisfaction The journal does not accept study protocols. The journal will consider case reports only if they make a valuable and original contribution to the literature. When considering submission of a paper utilizing publicly-available data authors should ensure that such studies add significantly to the body of knowledge and that they are validated using the authors’ own data through replication in an original sample. As of 1st April 2019, Infection and Drug Resistance will no longer consider meta-analyses for publication.
Author Instructions
Keywords staphylococcus aureus; biofilm; Risk factors; identification; Infectious and parasitic diseases; Pseudomonas aeruginosa; chlorquinaldol; skin and wound tissue infection; methicillin-resistant Staphylococcus aureus; mortality; thailand; incidence; antimicrobial stewardship; hardness; risk factor; methicillin-sensitive staphylococcus aureus; molecular typing; pvl gene; enterococci; quinine; antiinfective drug; antivirulence therapy; staphyloxanthin; target; dissolution; cre; carbapenems; aminoglycoside modifying enzyme; high level aminoglycosides resistance; chloroquine; assay; s. suis; s. suis infection; streptococcus suis; friability; uniformity of weight; visual inspection;